Your browser doesn't support javascript.
loading
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
Ogbuagu, Onyema; Segal-Maurer, Sorana; Ratanasuwan, Winai; Avihingsanon, Anchalee; Brinson, Cynthia; Workowski, Kimberly; Antinori, Andrea; Yazdanpanah, Yazdan; Trottier, Benoit; Wang, Hui; Margot, Nicolas; Dvory-Sobol, Hadas; Rhee, Martin S; Baeten, Jared M; Molina, Jean-Michel.
Affiliation
  • Ogbuagu O; Yale University School of Medicine, New Haven, CT, USA. Electronic address: onyema.ogbuagu@yale.edu.
  • Segal-Maurer S; New York Presbyterian-Queens, Flushing, NY, USA.
  • Ratanasuwan W; Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Brinson C; Central Texas Clinical Research, Austin, TX, USA.
  • Workowski K; Department of Medicine, Emory University, Atlanta, GA, USA.
  • Antinori A; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Roma, Italy.
  • Yazdanpanah Y; Paris Diderot University, Paris, France.
  • Trottier B; Clinique de Medecine Urbaine du Quartier Latin, Montréal, Québec, Canada.
  • Wang H; Gilead Sciences, Foster City, CA, USA.
  • Margot N; Gilead Sciences, Foster City, CA, USA.
  • Dvory-Sobol H; Gilead Sciences, Foster City, CA, USA.
  • Rhee MS; Gilead Sciences, Foster City, CA, USA.
  • Baeten JM; Gilead Sciences, Foster City, CA, USA.
  • Molina JM; Université de Paris Cité, Paris, France; Département de Maladies Infectieuses, Hôpitaux Saint-Louis, Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France; INSERM UMR 944, Paris, France.
Lancet HIV ; 10(8): e497-e505, 2023 08.
Article in En | MEDLINE | ID: mdl-37451297

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Lancet HIV Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Lancet HIV Year: 2023 Document type: Article Country of publication: